Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

ALK or ROS1-positive NSCLC × Crizotinib × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 3 Lung Neoplasms 2 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Multiple Endocrine Neoplasia Type 2a 1 Lymphoma, Non-Hodgkin 1 Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡